HIGH GLUCOSE AND TGF-BETA(1), STIMULATE FIBRONECTIN GENE-EXPRESSION THROUGH A CAMP RESPONSE ELEMENT

被引:53
作者
KREISBERG, JI [1 ]
GARONI, JA [1 ]
RADNIK, R [1 ]
AYO, SH [1 ]
机构
[1] AUDIE L MURPHY MEM VET ADM MED CTR, SAN ANTONIO, TX 78284 USA
关键词
D O I
10.1038/ki.1994.362
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Previously, we reported that mesangial cells increased fibronectin, laminin and type IV collagen synthesis when cultured in the presence of high glucose (30 mM). Although mRNA levels for all three extracellular matrix (ECM) proteins were also increased in high glucose conditions, the mechanism for this increase was not known. In order to determine whether increased transcription was involved in the observed increase in fibronectin mRNA levels mesangial cells were transfected with a construct containing the 5'-flanking region of the fibronectin (FN) gene [position +69 to -510 base pairs (bp)] fused to the coding region of the chloramphenicol acetyltransferase (CAT) gene [FN-CAT (-510)]. Cells were transiently and stably transfected with this construct. Under serum-free conditions, high glucose increased CAT activity only in the presence of TGF beta(1) (referred to as TGF beta). The experiments were performed without serum because FN-CAT (-510) contains a serum responsive element. The increase in CAT was approximately twofold in transiently transfected cells and threefold in stably transfected cells. TGF beta alone increased CAT activity approximately 30%. Stimulation of fibronectin gene expression appeared to occur at the level of a cAMP response element (CRE) located -170 bp of the FN gene because cells transfected with a construct containing an oligonucleotide encoding for this CRE fused to a minimal fibronectin promoter (-56 bp) and a CAT reporter gene [CRE (-170) FN-CAT] displayed similar increments of CAT activity after treatment with high glucose and TGF beta. Gel shift mobility assays with a CRE oligonucleotide revealed multiple complexes with mesangial cell nuclear proteins. No differences in the mobility or abundance of complexes were observed in the different conditions tested.
引用
收藏
页码:1019 / 1024
页数:6
相关论文
共 37 条
[21]   TGF-BETA-1 INDUCES PHOSPHORYLATION OF THE CYCLIC-AMP RESPONSIVE ELEMENT BINDING-PROTEIN IN ML-CC164 CELLS [J].
KRAMER, IM ;
KOORNNEEF, I ;
DELAAT, SW ;
VANDENEIJNDENVANRAAIJ, AJM .
EMBO JOURNAL, 1991, 10 (05) :1083-1089
[22]   VASOACTIVE AGENTS AFFECT MESANGIAL CELL-ADHESION [J].
KREISBERG, JI ;
VENKATACHALAM, MA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (04) :C505-C511
[23]   HIGH GLUCOSE ELEVATES C-FOS AND C-JUN TRANSCRIPTS AND PROTEINS IN MESANGIAL CELL-CULTURES [J].
KREISBERG, JI ;
RADNIK, RA ;
AYO, SH ;
GARONI, JA ;
SAIKUMAR, P .
KIDNEY INTERNATIONAL, 1994, 46 (01) :105-112
[24]   CYCLIC-AMP ASSOCIATED SHAPE CHANGE IN MESANGIAL CELLS AND ITS REVERSAL BY PROSTAGLANDIN-E2 [J].
KREISBERG, JI ;
VENKATACHALAM, MA ;
PATEL, PY .
KIDNEY INTERNATIONAL, 1984, 25 (06) :874-879
[25]   STRUCTURAL-FUNCTIONAL RELATIONSHIPS IN DIABETIC NEPHROPATHY [J].
MAUER, SM ;
STEFFES, MW ;
ELLIS, EN ;
SUTHERLAND, DER ;
BROWN, DM ;
GOETZ, FC .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (04) :1143-1155
[26]   FOS-ASSOCIATED PROTEIN-P39 IS THE PRODUCT OF THE JUN PROTO-ONCOGENE [J].
RAUSCHER, FJ ;
COHEN, DR ;
CURRAN, T ;
BOS, TJ ;
VOGT, PK ;
BOHMANN, D ;
TJIAN, R ;
FRANZA, BR .
SCIENCE, 1988, 240 (4855) :1010-1016
[27]  
Sambrook J., 1989, MOL CLONING LAB MANU
[28]   FOS-ASSOCIATED CELLULAR P39 IS RELATED TO NUCLEAR TRANSCRIPTION FACTOR-AP-1 [J].
SASSONECORSI, P ;
LAMPH, WW ;
KAMPS, M ;
VERMA, IM .
CELL, 1988, 54 (04) :553-560
[29]   REQUIREMENT FOR FOS GENE-EXPRESSION IN THE TRANSCRIPTIONAL ACTIVATION OF COLLAGENASE BY OTHER ONCOGENES AND PHORBOL ESTERS [J].
SCHONTHAL, A ;
HERRLICH, P ;
RAHMSDORF, HJ ;
PONTA, H .
CELL, 1988, 54 (03) :325-334
[30]   THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
SHAMOON, H ;
DUFFY, H ;
FLEISCHER, N ;
ENGEL, S ;
SAENGER, P ;
STRELZYN, M ;
LITWAK, M ;
WYLIEROSETT, J ;
FARKASH, A ;
GEIGER, D ;
ENGEL, H ;
FLEISCHMAN, J ;
POMPI, D ;
GINSBERG, N ;
GLOVER, M ;
BRISMAN, M ;
WALKER, E ;
THOMASHUNIS, A ;
GONZALEZ, J ;
GENUTH, S ;
BROWN, E ;
DAHMS, W ;
PUGSLEY, P ;
MAYER, L ;
KERR, D ;
LANDAU, B ;
SINGERMAN, L ;
RICE, T ;
NOVAK, M ;
SMITHBREWER, S ;
MCCONNELL, J ;
DROTAR, D ;
WOODS, D ;
KATIRGI, B ;
LITVENE, M ;
BROWN, C ;
LUSK, M ;
CAMPBELL, R ;
LACKAYE, M ;
RICHARDSON, M ;
LEVY, B ;
CHANG, S ;
HEINHEINEMANN, M ;
BARRON, S ;
ASTOR, L ;
LEBECK, D ;
BRILLON, D ;
DIAMOND, B ;
VASILASDWOSKIN, A ;
LAURENZI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986